OTC Pharmaceuticals - Malaysia | Statista Market Forecast

The OTC Pharmaceuticals market in Malaysia is projected to generate revenue of MYR US$889.10m in 2024.
It is expected to experience an annual growth rate of 4.61% (CAGR 2024-2029).
The largest market in this market is Other OTC Pharmaceuticals, which is estimated to have a market volume of MYR US$330.40m in 2024.
In comparison to other countries, the United States leads the market with revenue of US$41.24bn in 2024.
On a per capita basis, the revenue generated in Malaysia amounts to MYR US$25.64 per person in 2024.
The online sales channel is anticipated to contribute 12.45% of the total revenue in the OTC Pharmaceuticals market by 2024.
The demand for OTC pharmaceuticals in Malaysia is driven by the growing healthcare awareness and increasing accessibility to healthcare products.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Malaysia is experiencing significant growth due to several factors.

Customer preferences: Customers in Malaysia have shown a strong preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC medications do not require a prescription, allowing customers to easily purchase them from pharmacies and other retail outlets. Additionally, OTC medications are often more affordable than prescription drugs, making them a popular choice for customers seeking cost-effective healthcare solutions.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Malaysia is the increasing demand for self-medication. Customers are becoming more proactive in managing their health and are seeking OTC medications to treat common ailments such as headaches, colds, and allergies. This trend is driven by the growing awareness of healthcare and the availability of information through the internet and other sources. Customers are now more informed about their health conditions and are confident in their ability to choose and use OTC medications effectively.Another trend in the market is the rising popularity of herbal and traditional medicines. Traditional remedies have a long history in Malaysian culture and are often perceived as natural and safe alternatives to conventional medications. Customers are increasingly turning to herbal and traditional medicines for various health conditions, including digestive issues, joint pain, and stress relief. This trend is fueled by the growing interest in alternative medicine and the belief in the efficacy of natural remedies.

Local special circumstances: Malaysia has a well-developed healthcare system with a mix of public and private healthcare providers. The government plays a significant role in regulating the pharmaceutical industry, ensuring the safety and quality of OTC medications. The Ministry of Health is responsible for approving and monitoring the sale of OTC medications, ensuring that they meet the necessary standards and regulations. This regulatory framework provides customers with confidence in the safety and efficacy of OTC medications available in the market.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Malaysia is also influenced by macroeconomic factors such as population growth, urbanization, and rising disposable incomes. Malaysia has a growing population, particularly in urban areas, which increases the demand for healthcare products and services. Urbanization also leads to lifestyle changes and increased exposure to environmental factors, resulting in a higher incidence of health issues that can be treated with OTC medications.Rising disposable incomes in Malaysia have also contributed to the growth of the OTC Pharmaceuticals market. As people have more disposable income, they are willing to spend on healthcare products, including OTC medications. The increasing middle-class population in Malaysia has created a larger customer base for OTC pharmaceutical companies, driving market growth.In conclusion, the OTC Pharmaceuticals market in Malaysia is experiencing growth due to customer preferences for convenience and affordability, as well as the trends of self-medication and the popularity of herbal and traditional medicines. The local special circumstances, such as the well-regulated healthcare system, further contribute to the market's development. Additionally, underlying macroeconomic factors like population growth, urbanization, and rising disposable incomes are driving the demand for OTC medications in Malaysia.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.